SAN FRANCISCO — A few years ago, Genomic Expression CEO Gitte Pedersen was attending an evening party on the sidelines of the annual J.P. Morgan Healthcare Conference. She was talking with a well-known angel investor — whom she was also hoping to convince to invest in her RNA sequencing company.

She had met him several times in the past and had always found him to be professional.